Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Current Leases (2020 - 2025)

Palisade Bio (PALI) has disclosed Current Leases for 6 consecutive years, with $24000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Current Leases fell 81.54% to $24000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $24000.0, a 81.54% decrease, with the full-year FY2024 number at $90000.0, down 25.62% from a year prior.
  • Current Leases was $24000.0 for Q2 2025 at Palisade Bio, down from $58000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $184000.0 in Q2 2021 to a low of $24000.0 in Q2 2025.
  • A 5-year average of $107500.0 and a median of $111000.0 in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: surged 67.69% in 2023, then tumbled 81.54% in 2025.
  • Palisade Bio's Current Leases stood at $158000.0 in 2021, then crashed by 33.54% to $105000.0 in 2022, then increased by 15.24% to $121000.0 in 2023, then fell by 25.62% to $90000.0 in 2024, then plummeted by 73.33% to $24000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Current Leases are $24000.0 (Q2 2025), $58000.0 (Q1 2025), and $90000.0 (Q4 2024).